1. Mar 04, 2021

    Blinatumomab improves event-free survival in pediatric B-ALL

    Blinatumomab (Blincyto; Amgen) compared with consolidation chemotherapy before allogeneic hematopoietic stem cell transplantation (alloHSCT) in pediatric patients with high-risk first-relapse B-cell precursor acute lymphoblastic leukemia (B-ALL) improved event-free survival, according to data from a Phase 3 study published in JAMA.

    After a…

Subscribe

VIDEOS

Conference Roundup

  1. Feb 06, 2021

LRA highlights full continuum of lupus research at ACR Convergence 2020

The Lupus Research Alliance (LRA), the largest private funder of lupus research in the world, is proud to announce important results of 21 studies supported by the LRA to be presented at ACR Convergence 2020 – this year's virtual annual meeting of the American College of Rheumatology.…

View All

Journal Scan

  1. Mar 05, 2021

Systemic lupus erythematosus, lupus nephritis increases risk of cardiovascular disease

Compared with the general population, individuals with systemic lupus erythematosus (SLE) are at a greater risk of developing cardiovascular disease, according to a study, which also found that patients with lupus nephritis (LN) have a significantly…

View All

 


Resources